We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Outperforms Symptom Analysis in Detecting Ovarian Cancer

By MedImaging International staff writers
Posted on 27 Aug 2009
In a recent study, physicians compared symptom analysis to ultrasound in predicting ovarian cancer.

The researchers from the University of Kentucky Chandler Medical Center-Markey Cancer Center (Lexington, KY, USA) selected 272 women participating in yearly transvaginal screening (TVS) from 31,748 women enrolled in a free screening project at the university, comparing symptom results to ultrasound and surgical pathology findings. They found TVS performed better than symptoms analysis for detecting malignancies (73.3% versus 20% sensitivity).

Whereas symptoms analysis performed better for distinguishing benign tumors (91.3% versus 74.4% specificity), adding symptom analysis to TVS actually resulted in poorer identification of malignancy (sensitivity = 16.7%), even as it improved the ability to distinguish benign tumors (specificity = 97.9%).

The investigators reported that the data indicate that while symptoms do identify ovarian malignancies, they are not as accurate as TVS. They added that informative symptoms could be expected to be absent in 80% of ovarian malignancies.

The study was published in the August 15, 2009, issue of the journal Cancer.

Related Links:

University of Kentucky Chandler Medical Center-Markey Cancer Center



Digital Radiography System (Ceiling Free)
Digix CF Series
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Portable X-ray Unit
AJEX140H
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.